Olivier Pineau
GlaxoSmithKline (France)(FR)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Receptor Mechanisms and Signaling, Metabolism, Diabetes, and Cancer, Multiple Myeloma Research and Treatments, Neuropeptides and Animal Physiology
Most-Cited Works
- → Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains(2013)302 cited
- → Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents(2007)117 cited
- → Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPARγ agonists(2014)22 cited
- → Design, synthesis and evaluation of trifluoromethane sulfonamide derivatives as new potent and selective peroxisome proliferator-activated receptor α agonists(2007)10 cited
- → The discovery of equipotent PPARα/γ dual activators(2008)6 cited